Stocks and Investing Stocks and Investing
Mon, July 24, 2023
Sun, July 23, 2023
Fri, July 21, 2023

Douglas Tsao Maintained (APLS) at Strong Buy with Decreased Target to $82 on, Jul 21st, 2023


Published on 2024-10-28 05:02:14 - WOPRAI, Douglas Tsao
  Print publication without navigation


Douglas Tsao of HC Wainwright & Co., Maintained "Apellis Pharmaceuticals, Inc." (APLS) at Strong Buy with Decreased Target from $100 to $82 on, Jul 21st, 2023.

Douglas has made no other calls on APLS in the last 4 months.



There are 8 other peers that have a rating on APLS. Out of the 8 peers that are also analyzing APLS, 3 agree with Douglas's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Derek Archila of "Wells Fargo" Maintained at Hold with Decreased Target to $53 on, Thursday, July 20th, 2023
  • Laura Chico of "Wedbush" Maintained at Hold with Decreased Target to $40 on, Thursday, July 20th, 2023
  • Tiago Fauth of "Credit Suisse" Maintained at Hold with Increased Target to $81 on, Friday, May 5th, 2023


These are the ratings of the 5 analyists that currently disagree with Douglas


  • Anupam Rama of "JP Morgan" Maintained at Buy with Decreased Target to $72 on, Thursday, July 20th, 2023
  • Justin Kim of "Oppenheimer" Maintained at Buy with Increased Target to $108 on, Friday, May 12th, 2023
  • Steven Seedhouse of "Raymond James" Maintained at Strong Buy with Increased Target to $156 on, Friday, May 5th, 2023
  • Joseph Stringer of "Needham" Maintained at Strong Buy with Increased Target to $110 on, Friday, May 5th, 2023
  • Madhu Kumar of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $141 on, Friday, April 14th, 2023

Contributing Sources